GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Danaher Corp (MEX:DHR) » Definitions » Cyclically Adjusted PS Ratio

Danaher (MEX:DHR) Cyclically Adjusted PS Ratio : 5.00 (As of Jun. 02, 2025)


View and export this data going back to 2013. Start your Free Trial

What is Danaher Cyclically Adjusted PS Ratio?

As of today (2025-06-02), Danaher's current share price is MXN3550.00. Danaher's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was MXN709.64. Danaher's Cyclically Adjusted PS Ratio for today is 5.00.

The historical rank and industry rank for Danaher's Cyclically Adjusted PS Ratio or its related term are showing as below:

MEX:DHR' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 2.66   Med: 5.76   Max: 10.5
Current: 5.61

During the past years, Danaher's highest Cyclically Adjusted PS Ratio was 10.50. The lowest was 2.66. And the median was 5.76.

MEX:DHR's Cyclically Adjusted PS Ratio is ranked worse than
78.79% of 132 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.065 vs MEX:DHR: 5.61

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Danaher's adjusted revenue per share data for the three months ended in Mar. 2025 was MXN162.945. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is MXN709.64 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Danaher Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Danaher's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Danaher Cyclically Adjusted PS Ratio Chart

Danaher Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.51 10.16 7.62 7.28 6.86

Danaher Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.74 7.73 8.59 6.86 6.06

Competitive Comparison of Danaher's Cyclically Adjusted PS Ratio

For the Diagnostics & Research subindustry, Danaher's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Danaher's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Danaher's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Danaher's Cyclically Adjusted PS Ratio falls into.


;
;

Danaher Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Danaher's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=3550.00/709.64
=5.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Danaher's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Danaher's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=162.945/134.9266*134.9266
=162.945

Current CPI (Mar. 2025) = 134.9266.

Danaher Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 108.152 100.684 144.935
201509 84.942 100.392 114.162
201512 106.633 99.792 144.176
201603 96.901 100.470 130.133
201606 112.244 101.688 148.933
201609 113.926 101.861 150.908
201612 134.655 101.863 178.363
201703 112.214 102.862 147.194
201706 115.572 103.349 150.884
201709 116.465 104.136 150.902
201712 63.111 104.011 81.870
201803 120.231 105.290 154.074
201806 137.948 106.317 175.070
201809 127.747 106.507 161.835
201812 69.569 105.998 88.556
201903 113.937 107.251 143.339
201906 117.288 108.070 146.436
201909 118.512 108.329 147.609
201912 126.399 108.420 157.301
202003 143.855 108.902 178.233
202006 170.239 108.767 211.183
202009 179.461 109.815 220.499
202012 185.629 109.897 227.907
202103 190.701 111.754 230.243
202106 195.219 114.631 229.782
202109 204.460 115.734 238.366
202112 97.205 117.630 111.499
202203 207.504 121.301 230.813
202206 211.868 125.017 228.662
202209 209.033 125.227 225.225
202212 93.620 125.222 100.876
202303 145.457 127.348 154.114
202306 136.101 128.729 142.654
202309 131.336 129.860 136.461
202312 145.718 129.419 151.919
202403 128.496 131.776 131.568
202406 141.719 132.554 144.256
202409 156.518 133.029 158.751
202412 187.172 133.157 189.659
202503 162.945 134.927 162.945

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Danaher  (MEX:DHR) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Danaher Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Danaher's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Danaher Business Description

Address
2200 Pennsylvania Avenue, North West, Suite 800W, Washington, DC, USA, 20037-1701
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.